Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Agios Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- −3 vs. Q1 2025
- Shares held
- 61.7M
- +1.64M (+2.7%) vs. Q1 2025
- Total value
- $2.05B
- +$290.1M (+16.5%) vs. Q1 2025
- New holders
- 22
- 87 more added
- Sold out
- 25
- 77 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,081,470 | $36.0M | 0.03% | +217,971+25.2% | Added |
| Dimensional Fund Advisors LP | 1,106,093 | $36.8M | 0.01% | −155,980−12.4% | Reduced |
| Bank of America Corp | 1,120,308 | $37.3M | 0.00% | −15,284−1.3% | Reduced |
| Paradigm Biocapital Advisors LP | 1,142,511 | $38.0M | 1.62% | +1,142,511 | New |
| Armistice Capital, LLC | 1,168,000 | $38.8M | 1.47% | −880,000−43.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,279,754 | $42.6M | 1.70% | +209,900+19.6% | Added |
| Geode Capital Management, LLC | 1,405,755 | $46.8M | 0.00% | +11,174+0.8% | Added |
| Macquarie Group Ltd | 1,900,596 | $63.2M | 0.08% | +50,052+2.7% | Added |
| State Street Corp | 1,951,113 | $64.9M | 0.00% | −498,366−20.3% | Reduced |
| Price T Rowe Associates Inc | 2,274,249 | $75.6M | 0.01% | −27,104−1.2% | Reduced |
| Commodore Capital LP | 2,325,000 | $77.3M | 5.46% | +140,000+6.4% | Added |
| Erste Asset Management GmbH | 2,326,489 | $77.4M | 0.65% | +96,589+4.3% | Added |
| Bellevue Group AG | 3,590,150 | $119.4M | 2.63% | +75,000+2.1% | Added |
| BlackRock, Inc. | 4,833,760 | $160.8M | 0.00% | −274,986−5.4% | Reduced |
| Vanguard Group Inc | 5,682,019 | $189.0M | 0.00% | +77,428+1.4% | Added |
| Farallon Capital Management, L.L.C. | 5,767,466 | $191.8M | 0.87% | +67,000+1.2% | Added |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −1,002,036−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −235,350−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −150,511−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −41,029−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −37,920−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −29,749−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −27,753−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −27,688−100.0% | Sold out |
| Allen Investment Management LLC | 0 | $0 | 0.00% | −21,781−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,801−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,188−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −11,622−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −10,768−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,553−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −8,750−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,544−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,365−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,314−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Kodai Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |